Kidney Transplantation in Primary Oxalosis: Data From the EDTA Registry by Broyer, M. et al.
Nephrol Dial Transplant (1990) 5: 332-336
© 1990 European Dialysis and Transplant Association-European
Renal Association
Nephrology
Dialysis
Transplantation
Registry Report
Kidney Transplantation in Primary Oxalosis: Data From the EDTA
Registry
M. Broyer Hopital Necker Enfants-Malades,
Paris, France
F. P. Brunner* Departement fur Innere Medizin,
Universitat Basel, Switzerland
H. Brynger Department of Surgery 1, Sahlgrenska
Sjukhuset, Goteborg, Sweden
S. R. Dykes St Thomas' Hospital, London, United
Kingdom
J. H. H. Ehrich Medizinische Hochschule Hannover,
Federal Republic of Germany
""Chairman
W. Fassbinder Stadtische Kliniken Fulda,
Federal Republic of Germany
W. Geerlings Stichting Thuisdialyse Noord
Nederland, Haren, Netherlands
G. Rizzoni Ospedale Pediatrico Bambino
Gesii, Istituto di Ricerca
Scientifica, Roma, Italy
N. H. Selwood St Thomas' Hospital, London,
United Kingdom
G. Tufveson Transplantation Unit, University
Hospital, Uppsala, Sweden
A. J. Wing St Thomas' Hospital, London,
United Kingdom
Abstract. This paper reports the results of 98 first kidney
transplantations in patients with oxalosis as the primary
renal disease as recorded by the EDTA Registry. There
were 79 patients who received a cadaveric (CAD) graft
and 15 patients with a living related donor (LRD) graft;
the type of donor was not recorded for four patients.
Initial graft survival appeared to be better after LRD as
compared to CAD grafts but at 3 years the poor survival
was similar with 23% for LRD and 17% for CAD grafts.
CAD graft survival did not differ between children and
adults and was not affected by the waiting time on dialysis.
A slight improvement was observed in grafts performed in
the years 1983-1986 as compared to grafts performed in
earlier years. The causes of failure reported were mainly
rejection (33%) and recurrence of primary renal disease
(31 %). In view of the poor results related to recurrence of
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oxalosis in the graft, the potential of combined kidney and
liver transplantation is discussed.
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Introduction
Primary hyperoxaluria, a synonym for congenital
oxalosis, is a rare metabolic disorder caused by accumu-
lation of glyoxylate, which leads to increased synthesis
and excretion of glycolate and oxalate. The basic
biochemical defect described in 1986 by Danpure and
Jennings [1], seems to be the absence of peroxisomal
alanine glyoxylate aminotransferase, which is located
exclusively in the liver. The disease is characterised clini-
cally by recurrent calcium oxalate kidney stones and
nephrocalcinosis resulting in progressive renal insuffi-
ciency. Once end-stage renal failure is reached, further
calcium oxalate accumulation cannot be prevented by any
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form of dialysis strategy and leads to extrarenal com-
plications with progressive and severely disabling bone
disease being the most prominent [2]. Calcification of
blood vessels and heart may also occur and cause death
[3]. For these reasons, dialysis is quite unsatisfactory and
explains why kidney transplantation has been attempted
in spite of the almost inevitable recurrence of calcinosis in
the graft. Several reports of unsuccessful or successful
renal transplantation in patients with primary oxalosis
have been published [4,16]. Since successful cases may
be reported preferentially, and in order to have a
more general view on renal transplantation in primary
oxalosis, it was decided to analyse the outcome of all such
kidney grafts reported to the Registry of the European
Dialysis and Transplant Association—European Renal
Association (EDTA Registry) up to 31 December 1966.
Methods
This study is based on information obtained through
individual patient questionnaires that have been collected
each year since 1965 by the EDTA Registry. The essential
structure of the patient questionnaire has remained
largely unchanged since 1971 [17]. The coding structure
for primary renal diseases was altered in 1973, at which
time code 53 was introduced for 'oxalosis'. The definition
of code 53 was modified in 1985 to 'primary oxalosis', in
order to exclude the rare forms of end-stage renal failure
due to secondary hyperoxaluria. Since restricting the
study to those cases registered since 1985 would result in
too few cases for study, it was felt reasonable to include
all cases of oxalosis reported to the Registry. Secondary
oxalosis is known to occur more commonly in the older
age groups, carries a better prognosis than primary
oxalosis, and is also uncommon. For this reason, studying
all cases of oxalosis was considered unlikely to affect the
results adversely. The method of calculating actuarial
survival using life table methods has been previously
described [18].
Results
There were 221 patients reported to the Registry up to 31
December 1986 with oxalosis recorded as the primary
renal disease: 121 males, 99 females and one with the sex
not recorded. The age distribution at start of treatment is
given in Fig. 1. Figure 2 shows the age distribution of 79
patients at the time of receiving their first cadaveric
graft. Sixty per cent of these graft recipients were younger
than 25. The number of new patients accepted for renal
replacement therapy per year varied from 9 to 22 in the
last 10 years. The number of grafts performed yearly
seemed to increase slightly from 1976 to 1986 (Fig. 3).
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Fig. 1. Age distribution at start of renal replacement therapy of 221
patients with oxalosis.
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Fig. 2. Age distribution at first cadaveric graft of patients with oxalosis.
Of a total of 98 patients who received a first transplant
(79 cadaveric, 15 living donor and 4 where the source was
not recorded), 76% were performed since 1980 and 58%
since 1983. The waiting time on dialysis before grafting
was variable; five patients were grafted directly without
dialysis, 35 were grafted within the first year, 21 within the
second year and 36 after a longer interval. In one case, the
treatment history prior to transplantation had not been
reported to the Registry.
Graft survival, shown in Table 1 and Fig. 4, appeared
to be better initially after living related as compared to
cadaveric grafting, but this was not sustained. Primary
non-function was recorded for 11 % of first cadaveric
grafts. Cadaver graft survival was no different in children
compared to adults (Fig. 5) and no living donor graft was
performed in patients under the age of 15. Graft survival
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Table 1. First cadaveric graft survival in patients with oxalosis (n = 79) Graft Survival (%)
100-1
Interval n at risk
Interval n failed
Cumulative survival (%)
Months
0-6
77
42
45
7-12
28
5
32
13-24
20
2
29
25-26
15
6
17
Graft Survival (%)
50-
First LRD graft (n=15)
First CAD graft (n=79)
1983-1986 (n=36)
before 1983 (n=41)
34% 21%
Years
Fig. 6. First cadaver graft survival according to year of grafting.
was slightly better for transplants performed more
recently, that is between January 1983 and December
1986 (Fig. 6), in keeping with improving graft survival for
other primary renal diseases [19,20]. Graft survival was
also computed according to waiting time on dialysis: no
17%
 difference was found between patients grafted within or
after the first year of starting treatment (Fig. 7).
0 , ~"2 " I Of the first grafts that failed, 88% did so within the first
Years year. Among the causes reported for these, only 33% were
Fig. 4. First graft actuarial survival according to source of graft. Primary r e l a t e d t o rejection compared to 70%-85% in patients
non-function was recorded for 11% of CAD grafts. with other primary renal diseases [21]. Recurrence of
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Fig. 7. First cadaver graft survival according to time on dialysis prior to
transplantation.
oxalosis in the graft was recorded as the cause of graft
failure in 31%. These proportions were similar for the
eight second graft failures.
Patient survival after grafting in 1980-1986 and for all
patients with oxalosis starting renal replacement therapy
during the same period is shown in Table 2. Despite the
high graft failure rate, mortality appeared to be similar, or
only slightly higher, after grafting. This resulted in a
cumulative actuarial survival of 74% at 3 years after
receiving a first cadaver or living donor graft. Actuarial
survival, irrespective of the mode or renal replacement
therapy, was 79% at 3 years. This compares unfavourable
to patients with the common primary renal diseases of
similar age distribution, who were found to have a 5-year
cumulative survival above 80% [19].
Table 2. Per cent actuarial patient survival
After first graft (n = 60)
On RRT (including grafting n = 122)
1980-1986
Year
1
85
91
2
85
87
3
74
79
The distribution of the main causes of death was
studied and the results are shown in Table 3 according to
whether the patient had ever received a transplant. There
were slightly less than twice as many deaths in ungrafted
than grafted patients. Cardiovascular causes were the
most frequent (51 %) with infection second (14%). Deaths
from infection were rarely recorded in ungrafted patients.
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Table 3. Per cent distribution of causes of death according to whether or
not the patient had ever received a transplant
Cardiac Vascular Infection Therapy Other
ceased
Ungrafted (%)
(n = 69)
Grafted (%)
(7i = 39)
All (%)
(7i=108)
41
36
39
16
5
12
4
31
14
6
3
5
33
25
31
Cardiovascular causes, on the other hand, were more
frequent (57%) in ungrafted patients than in those who
had received a transplant at some time (41 %).
Discussion
Historically, renal transplantation was considered as
contraindicated in primary hyperoxaluria [4,5]. This atti-
tude was confirmed by several reports which recorded
poor graft survival due to oxalate deposition in the trans-
planted kidney [6,10]. Nevertheless, there were some
publications reporting a single or a small number of
successful kidney transplants [11,15]. These reports
stressed the importance of specific measures such as
intensive dialysis at time of grafting, and pyridoxine
administration, which may decrease oxalate deposition in
the graft. The largest series with well-defined prophylactic
medical treatment was reported in 1984 by Scheinmann et
al [16]. It included ten living related donor transplants, of
whom seven had a functioning graft 1-7 years later, and
one cadaver graft that lasted for 9 years. Considered
together with the poor prognosis of patients with primary
oxaluria on any form of dialysis therapy, these limited but
rather optimistic reports probably encouraged continued
attempts with kidney transplantation in patients with
primary oxalosis, since the number of grafts per year
recorded in the EDTA Registry increased between 1982
and 1986.
This report confirms the poor prognosis of kidney
transplantation in patients recorded by the EDTA
Registry with the diagnosis of oxalosis, although it is
important to keep in mind that, before 1985, some
patients with secondary oxalosis may have been registered
under the same code. Since secondary oxalosis is either
related to acute but transient oxalate intoxication or to
uncontrolled, though in principle controllable, enteric
hyperabsorption of oxalate, kidney transplantation for
secondary oxalosis is likely to have a much better prog-
nosis. Thus, the low graft survival rates reported here
might still overestimate the true situation concerning
primary hyperoxaluria.
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Recipients of living related donor transplants run a
lower risk of oliguria due to ischaemic damage at trans-
plantation or due to rejection episodes. It is not surpris-
ing, therefore, that fewer living related donor grafts were
lost during the early post-transplant months. However,
their failure rate was higher thereafter and resulted in a
graft survival that was as low at 3 years as in cadaveric
grafts (Fig. 4).
End-stage renal failure occurring in childhood might
point to a more severe form of oxalosis. However, graft
survival was no better in adults than in children, indi-
cating that once on dialysis the oxalate pool size would
probably have the same potentially deleterious effect on
the graft. This is also reflected by similarly poor graft
survival irrespective of the waiting time on dialysis (Fig.
7). Finally it is also disappointing to note only a slight
improvement of graft survival due to fewer early failures
but with a similar late failure rate in more recent years.
The poor prognosis of kidney transplantation in patients
with primary hyperoxaluria may lend support to another
approach, namely combined hepatic and renal transplan-
tation [22]. Whether or not correction of the underlying
metabolic disorder by this approach will improve the
outlook for patients with primary oxalosis remains yet to
be clearly demonstrated.
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